Abstract

Author SummaryInfectious diseases remain a major health and socioeconomic problem in many low-income countries, particularly in sub-Saharan Africa. For many years, the three most devastating diseases, HIV/AIDS, malaria, and tuberculosis (TB) have received most of the world's attention. However, in rural and impoverished urban areas, a number of infectious diseases remain neglected and cause massive suffering. It has been calculated that a group of 13 neglected infectious diseases affects over one billion people, corresponding to a sixth of the world's population. These diseases include infections with different types of worms and parasites, cholera, and sleeping sickness, and can cause significant mortality and severe disabilities in low-income countries. For most of these diseases, vaccines are either not available, poorly effective, or too expensive. Moreover, these neglected diseases often occur in individuals who are also affected by HIV/AIDS, malaria, or TB, making the problem even more serious and indicating that co-infections are the rule rather than the exception in many geographical areas. To address the importance of combating co-infections, scientists from 14 different countries in Africa and Europe met in Addis Ababa, Ethiopia, on September 9–11, 2007. The message coming from these scientists is that the only possibility for winning the fight against infections in low-income countries is by studying, in the most global way possible, the complex interaction between different infections and conditions of malnourishment. The new scientific and technical tools of the post-genomic era can allow us to reach this goal. However, a concomitant effort in improving education and social conditions will be needed to make the scientific findings effective.

Highlights

  • Background and RationaleInfectious diseases remain a major health and socioeconomic problem in many low-income countries, in sub-Saharan Africa

  • It has been calculated that a group of 13 neglected infectious diseases (NIDs), including Buruli ulcer (Mycobacterium ulcerae), cholera (Vibrio cholerae), cysticercosis, dracunculiasis (Guinea worm), trematodal infections, hydatidosis, leishmaniasis, lymphatic filariasis, onchocerciasis, schistosomiasis, helminthiasis, trachoma (Chlamidia trachomatis), and trypanosomiasis (African sleeping sickness, Chagas disease), affect over one billion people [4]

  • NIDs often occur in individuals that are affected by HIV/ AIDS, malaria, or TB, indicating that coinfections are the rule rather than the exception in many geographical areas [2

Read more

Summary

Background and Rationale

Infectious diseases remain a major health and socioeconomic problem in many low-income countries, in sub-Saharan Africa. It has been calculated that a group of 13 NIDs, including Buruli ulcer (Mycobacterium ulcerae), cholera (Vibrio cholerae), cysticercosis, dracunculiasis (Guinea worm), trematodal infections, hydatidosis, leishmaniasis, lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis, helminthiasis, trachoma (Chlamidia trachomatis), and trypanosomiasis (African sleeping sickness, Chagas disease), affect over one billion people (corresponding to a sixth of the world’s population) [4]. The new commitment to NIDs in FP7 creates an unprecedented opportunity to actively address the scientific challenges associated with co-infections between HIV/AIDS, malaria, TB, and NIDs. In addition, the Special Programme for Research and Training in Tropical Diseases of the World Health Organization (WHO/TDR) has shown renewed interest for translational research in NIDs. The recently updated strategy of WHO/TDR aims to support research on neglected needs by fostering innovation for product development, and for access to interventions [7].

Author Summary
Objectives
Findings
Conclusions and Perspectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.